ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Intravenous (IV) Solutions Market Is Expected To Propel Growth Based on Increasing Prolonged Illnesses And Extended Period of Hospitalization Till 2024 | Million Insights

Intravenous (IV) Solutions Market Is Expected To Propel Growth Based on Increasing Prolonged Illnesses And Extended Period of Hospitalization Till 2024 | Million Insights
Million Insights - World's Fastest Growing Market Research Database
According to new report available with Million Insights, the global intravenous solutions industry is predicted to grow at a CAGR of 7.8% in the forecast period, providing numerous opportunities for market players to invest in research and development of the market.

The global Intravenous (IV) Solutions Market was appreciated at US$ 6.9 billion in the year 2015. It is estimated to develop at a CAGR of 7.8% for the duration of the prediction. The development of this market is credited to the speedily developing elderly people and occurrence of undernourishment in the pediatric and the aging populace. Growing prolonged illnesses, extended period of hospitalization, and the initiative taken by the government projected to increase the market above the prediction period.

The Intravenous (IV) Solutions market on the source of Type of Nutrients could span Minerals & Vitamins [Salt & Electrolyte], Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Carbohydrates. The subdivision of Single Dose Amino Acid Solution seized a substantial stake during the past year. It was carefully tracked by the subdivision of Parenteral Lipid Emulsions.

Full Research Report On Global Intravenous (IV) Solutions Market Analysis available at: https://www.millioninsights.com/industry-reports/intravenous-iv-solutions-market 

Growing occurrence of Hepatic sicknesses, failure of kidney, sicknesses due to the deficit of protein [Kwashiorkor & Marasmus] backing to the greater ingestion of amino acid injections. Furthermore, augmented supports to superior amino acids by way of smaller amount of adversarial properties are likewise powering the development of the market.

The Intravenous (IV) Solutions market on the source of Type could span Peripheral Parenteral Nutrition [PPN], Total Parenteral Nutrition [TPN]. The subdivision of Total Parenteral Nutrition [TPN] retained a mainstream stake in past year, due to the increasing uses by the pediatric and elderly people together with its necessity in the administration of long-lasting sicknesses for example ulcerative colitis and cancer.

The occurrence of cancer is predicted to speedily upturn in the following a small number of years. Stomach cancer is one of the best five cancers disturbing the people. These patients are unable to eat by mouth, and need to depend on Total Parenteral Nutrition [TPN] for existence. Furthermore, numerous patients suffering from progressive cancer grow anorexia.

It shrinks their time of existence. These patients react poorly to chemotherapy.

The Intravenous (IV) Solutions market on the source of Type of End User could span Ambulatory Surgery Centers, Hospitals, Private Clinic, and Others. The Intravenous (IV) Solutions industry on the source of Area with respect to Trades in terms of intake, Profits, Market stake and Development percentage in these areas, for the duration of the prediction could span North America, Europe, Asia Pacific, Latin America, and Middle East &Africa.

By the source of geography, North America ruled the market in the past year. Furthermore, the area experienced severe scarcity of IV fluids owing to augmented hospitalization of respiratory tract infection patients during the period of past year. The set-up of compensation is encouraging for IV nourishment. In the emerging nations, growing purchase power pays the nonexistence of compensation exposure accordingly supporting the development.

Asia Pacific is projected to be the speedily developing area. The increasing elderly inhabitants in China and Japan, growing inclinations of ingestion of unhealthy foodstuff, and low-slung level of alertness are projected to encourage the development of the market of IV solutions in this area. India is one of the speedily developing nations owing to growing private resources and government inventiveness in the area.

The statement revises Trades in terms of intake of Intravenous (IV) Solutions in the market; particularly in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. It concentrates on the topmost companies operating in these regions. Some of the important companies operating in the field at the international level are Baxter, B. Braun Melsungen AG, Hospira Inc., and Fresenius Kabi AG. Additional notable companies operating in the field are Vifor Pharma, JW Life Science, ICU Medical, Inc., Sichuan Kelun Pharmaceutical, Omnicare, and Grifols.

Request for Free Sample Copy at: https://www.millioninsights.com/industry-reports/intravenous-iv-solutions-market/request-sample

Market Segment:

Type Outlook (Market revenue in USD Million, 2013 - 2024)

    • Total Parenteral Nutrition (TPN)

    • Peripheral Parenteral Nutrition (PPN)

Nutrient Outlook (Market Revenue in USD Million, 2013 - 2024)

    • Carbohydrates

    • Single dose amino acid solution

    • Vitamins & minerals (salt and electrolyte)

    • Parenteral lipid emulsion

    • Others (trace elements)

Regional Outlook (Market Revenue in USD Million, 2013 - 2024)

    • North America

        • U.S.

        • Canada

    • Europe

        • UK

        • Germany

    • Asia Pacific

        • Japan

        • China

        • India

        • Australia

    • Latin America

        • Brazil

        • Mexico

    • Middle East and Africa

        • South Africa

Related Reports of this Category available at Million Insights: https://www.millioninsights.com/industry/medical-devices

About Million Insights
Million Insights, is a distributor of market research reports, published by premium publishers only. We have a comprehensive market place that will enable you to compare data points, before you make a purchase. Enabling informed buying is our motto and we strive hard to ensure that our clients get to browse through multiple samples, prior to an investment. Service flexibility & the fastest response time are two pillars, on which our business model is founded. Our market research report store, includes in-depth reports, from across various industry verticals, such as healthcare, technology, chemicals, food & beverages, consumer goods, material science & automotive.

For More Information: www.millioninsights.com

Media Contact
Company Name: Million Insights
Contact Person: Ryan Manuel
Email: Send Email
Phone: 91-20-65300184
Address:Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar
City: Pune
State: Maharashtra
Country: India
Website: www.millioninsights.com/industry-reports/intravenous-iv-solutions-market



Source: www.abnewswire.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.